New Whitepaper: The Microbiome in Clinical Trials – Opportunities and Challenges
Medpace and Diversigen discuss the opportunities and challenges of the microbiome in clinical trials in a recently published whitepaper. You can access the whitepaper in…
Q&A with Dr. Brian Murphy, VP of Medical Affairs for Infectious Diseases
In this post, Dr. Brian Murphy, Vice President of Medical Affairs for Infectious Diseases, discusses the following topic: “Source Control Review in Clinical Trials of…
The Promising Landscape of Microbiome-based Clinical Research
Recent discoveries have been made that have revealed the power of microbes to prevent, diagnose, and treat disease. As a result of these discoveries, clinical…
Medpace and IHMA Announce Strategic Alliance to Provide Microbiology Laboratory Services for Clinical Studies
Medpace, a global full service Contract Research Organization (CRO) and International Health Management Associates, Inc. (IHMA), a full service central...